No association of common VCP variants with sporadic frontotemporal dementia

Axel Schumacher1, Patricia Friedrich, Janine Diehl

  • 1Neurochemistry and Neurogenetics Laboratory, Department of Psychiatry, TU-Munich, Germany.

Neurobiology of Aging
|July 10, 2007
PubMed

Insights

Genetic analysis of the VCP gene in sporadic frontotemporal dementia (FTD) revealed no significant association. Common variants in VCP do not appear to strongly influence the risk of developing sporadic FTD.

Area of Science:

  • Neurogenetics
  • Molecular Neurology
  • Human Genetics

Background:

  • Mutations in the valosin containing protein (VCP) gene are linked to autosomal dominant inclusion body myopathy with Paget disease and frontotemporal dementia (IBMPFD).
  • The role of VCP in sporadic forms of frontotemporal dementia (FTD) remains largely unexplored.
  • Understanding genetic factors in FTD is crucial for diagnosis and therapeutic development.

Purpose of the Study:

  • To investigate the potential association between common variants in the VCP gene and sporadic FTD.
  • To determine if VCP gene variations contribute to the risk of developing non-familial FTD.

Main Methods:

  • Genotyping of 27 single nucleotide polymorphisms (SNPs) across the entire VCP genomic region.
  • Case-control study design involving 198 patients with sporadic FTD and 184 matched healthy controls from Germany.
  • Statistical analysis to assess the association between VCP variants and FTD risk.

Main Results:

  • No statistically significant association was found between the genotyped VCP single nucleotide polymorphisms and sporadic FTD.
  • The study found no evidence to suggest that common VCP variants confer a strong risk for the development of sporadic FTD.

Conclusions:

  • Common variants in the VCP gene are unlikely to be a major genetic risk factor for sporadic FTD.
  • Further research may be needed to explore rarer VCP variants or other genetic contributors to sporadic FTD.

Related Concept Videos

Association Areas of the Cortex01:21

Association Areas of the Cortex

Association areas are regions of the cerebral cortex that do not have a specific sensory or motor function. Instead, they integrate and interpret information from various sources to enable higher cognitive processes such as memory, learning, and decision-making. Some key association areas include the following:
Prefrontal Association Area: This area is located in the frontal lobe and is involved in planning, decision-making, and moderating social behavior. It connects with primary motor areas,...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...